Sökning: onr:"swepub:oai:DiVA.org:oru-63296" >
Availability of hep...
Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries
-
- Leblebicioglu, Hakan (författare)
- Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University, Medical School, Samsun, Turkey
-
- Arends, Joop E. (författare)
- Internal Medicine and Infectious Diseases, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands
-
- Ozaras, Resat (författare)
- Department of Infectious Diseases and Clinical Microbiology, Istanbul University Cerrahpasa Medical School, Istanbul, Turkey
-
visa fler...
-
- Corti, Giampaolo (författare)
- Infectious Disease Unit, University of Florence School of Medicine, Florence, Italy
-
- Santos, Lurdes (författare)
- Infectious Diseases Service C Hospitalar São João, Faculty of Medicine, Alameda Professor Hernani Monteiro, Porto, Portugal
-
- Boesecke, Christoph (författare)
- Department of Medicine I, Bonn University, Bonn, Germany
-
- Ustianowski, Andrew (författare)
- Infectious Diseases & Tropical Medicine and Research Lead, North Western Infectious Diseases Unit, Pennine Acute Hospitals NHS Trust, North Manchester General Hospital, Manchester, UK
-
- Duberg, Ann-Sofi, 1957- (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper,Department of Infectious Diseases, Örebro University Hospital, Örebro, Sweden
-
- Ruta, Simona (författare)
- Stefan S. Nicolau Institute of Virology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
-
- Salkic, Nermin N. (författare)
- Department of Gastroenterology and Hepatology, University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina
-
- Husa, Petr (författare)
- Infectious Diseases, Masaryk University, Brno, Czech Republic; Infectious Diseases, University Hospital Brno, Brno, Czech Republic
-
- Lazarevic, Ivana (författare)
- Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
-
- Pineda, Juan A. (författare)
- Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, Sevilla, Spain
-
- Pshenichnaya, Natalia Yurievna (författare)
- Rostov State Medical University, Rostov-on-Don, Russia
-
- Tsertswadze, Tengiz (författare)
- Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia; Faculty of Medicine, Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia
-
- Matičič, Mojca (författare)
- Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre, Ljubljana, Slovenia
-
- Puca, Edmond (författare)
- Department of Infection Diseases, University Hospital Center, Tirane, Albania
-
- Abuova, Gulzhan (författare)
- Infectious Diseases Department, South - Kazakhstan State Pharmaceutical Academy, Shymkent, Kazakhstan
-
- Gervain, Judit (författare)
- Division Hepato-Pancreatology, 1st Department of Gastroenterology and Molecular Diagnostic Laboratory, "Szent György" Teaching Hospital Székesfehérvár, Székesfehérvár, HungaryDivision Hepato-Pancreatology, 1st Department of Gastroenterology and Molecular Diagnostic Laboratory, "Szent György" Teaching Hospital Székesfehérvár, Székesfehérvár, Hungary
-
- Bayramli, Ramin (författare)
- Department of Microbiology and Immunology, Azerbaijan Medical University, Educational Therapeutic Hospital, Baku, Azerbaijan
-
- Ahmeti, Salih (författare)
- Infectious Disease Clinic, University Clinical Centre of Kosova, Faculty of Medicine, Prishtina University, Pristina, Kosovo
-
- Koulentaki, Mairi (författare)
- Department of Gastroenterology, University Hospital of Heraklion, Heraklion, Crete, Greece
-
- Kilani, Badreddine (författare)
- Service des Maladies Infectieuses, Faculté de Médecine de Tunis, Université Tunis EL Manar, Hôpital la Rabta, Tunis, Tunisia
-
- Vince, Adriana (författare)
- University Hospital of Infectious Diseases, Zagreb School of Medicine, Zagreb, Croatia
-
- Negro, Francesco (författare)
- Divisions of Gastroenterology and Hepatology of Clinical Pathology, University Hospital of Geneva, Geneva, Switzerland
-
- Sunbul, Mustafa (författare)
- Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University, Medical School, Samsun, Turkey
-
- Salmon, Dominique (författare)
- Infectious Diseases, Hôpitaux Universitaires Paris Centre, Université Paris Descartes, Paris, France
-
visa färre...
-
(creator_code:org_t)
- Amsterdam, Netherlands : Elsevier, 2018
- 2018
- Engelska.
-
Ingår i: Antiviral Research. - Amsterdam, Netherlands : Elsevier. - 0166-3542 .- 1872-9096. ; 150, s. 9-14
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: Treatment with direct acting antiviral agents (DAAs) has provided sustained virological response rates in >95% of patients with chronic hepatitis C virus (HCV) infection. However treatment is costly and market access, reimbursement and governmental restrictions differ among countries. We aimed to analyze these differences among European and Eurasian countries.METHODS: A survey including 20-item questionnaire was sent to experts in viral hepatitis. Countries were evaluated according to their income categories by the World Bank stratification.RESULTS: Experts from 26 countries responded to the survey. As of May 2016, HCV prevalence was reported as low (≤1%) in Croatia, Czech Republic, Denmark, France, Germany, Hungary, the Netherlands, Portugal, Slovenia, Spain, Sweden, UK; intermediate (1-4%) in Azerbaijan, Bosnia and Herzegovina, Italy, Kosovo, Greece, Kazakhstan, Romania, Russia, Serbia and high in Georgia (6.7%). All countries had national guidelines except Albania, Kosovo, Serbia, Tunisia, and UK. Transient elastography was available in all countries, but reimbursed in 61%. HCV-RNA was reimbursed in 81%. PegIFN/RBV was reimbursed in 54% of the countries. No DAAs were available in four countries: Kazakhstan, Kosovo, Serbia, and Tunisia. In others, at least one DAA combination with either PegIFN/RBV or another DAA was available. In Germany and the Netherlands all DAAs were reimbursed without restrictions: Sofosbuvir and sofosbuvir/ledipasvir were free of charge in Georgia.CONCLUSION: Prevalence of HCV is relatively higher in lower-middle and upper-middle income countries. DAAs are not available or reimbursed in many Eurasia and European countries. Effective screening and access to care are essential for reducing liver-related morbidity and mortality.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
Nyckelord
- Availability of hepatitis C diagnostics
- Therapeutics in European and Eurasia countries
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Leblebicioglu, H ...
-
Arends, Joop E.
-
Ozaras, Resat
-
Corti, Giampaolo
-
Santos, Lurdes
-
Boesecke, Christ ...
-
visa fler...
-
Ustianowski, And ...
-
Duberg, Ann-Sofi ...
-
Ruta, Simona
-
Salkic, Nermin N ...
-
Husa, Petr
-
Lazarevic, Ivana
-
Pineda, Juan A.
-
Pshenichnaya, Na ...
-
Tsertswadze, Ten ...
-
Matičič, Mojca
-
Puca, Edmond
-
Abuova, Gulzhan
-
Gervain, Judit
-
Bayramli, Ramin
-
Ahmeti, Salih
-
Koulentaki, Mair ...
-
Kilani, Badreddi ...
-
Vince, Adriana
-
Negro, Francesco
-
Sunbul, Mustafa
-
Salmon, Dominiqu ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Infektionsmedici ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Farmakologi och ...
- Artiklar i publikationen
-
Antiviral Resear ...
- Av lärosätet
-
Örebro universitet